Allogene Therapeutics, Inc. (ALLO) Tops Q3 EPS by 3c

Allogene Therapeutics, Inc. (NASDAQ: ALLO) reported Q3 EPS of ($0.19), $0.03 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Allogene Therapeutics, Inc. (ALLO) click here.

You May Also Be Interested In

• Vail Resorts (MTN) 2200 contracts October 145 puts trade into quarter results
• Us 10-year Treasury Yield Rises 10 Basis Points On Day To 5.27%
• ConAgra Brands (CAG) call put ratio 3.2 calls to 1 put into quarter results